Doctor profile · Federal record
Dr. STELLA QUIASON, M.D.
Specialist (CMS: GASTROENTEROLOGY) · OLATHE, KS
- NPI 1770500795
- Accepts Medicare
- MIPS 75.3 / 100 · 2023
- 40 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
20375 W 151ST ST, 203
OLATHE, KS 660615306
(913) 393-9898
fax (913) 393-9893
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- September 21, 2011
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- Kansas #0429135
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1770500795. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
743
Distinct HCPCS
10
Medicare allowed
$100,317
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
43239 |
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 134 | 130 | $96 | |
45385 |
Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 132 | 128 | $230 | |
45380 |
Biopsy of large bowel using a flexible endoscope | 123 | 122 | $130 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 70 | 66 | $122 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 59 | 55 | $119 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 53 | 36 | $74 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 45 | 44 | $84 | |
G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk | 44 | 44 | $161 | |
43235 |
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | 18 | $92 | |
G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | 18 | $164 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 53. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$75
Transactions
4
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 4 | $74.58 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
459
Patients
139
Total drug cost
$238,084
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Pantoprazole Sodium | Generic | 216 | 92 | $3,425 |
| Famotidine | Generic | 52 | 15 | $682 |
| Omeprazole | Generic | 33 | 15 | $317 |
| Sucralfate | Generic | 25 | 17 | $1,030 |
| Ursodiol | Generic | 20 | 0 | $4,341 |
| Rabeprazole Sodium | Generic | 17 | 0 | $526 |
| Ondansetron Hcl | Generic | 16 | 0 | $159 |
| Dicyclomine Hcl | Generic | 15 | 0 | $184 |
| Humira(Cf) Pen (Adalimumab) | Brand | 14 | 0 | $209,341 |
| Movantik (Naloxegol Oxalate) | Brand | 14 | 0 | $5,915 |